by Esme Fowler-Mason | May 7, 2026 | Access to Care, NCD Solutions, News, Uncategorized
The devices are available. The prices are negotiated. So why aren’t patients benefiting? Across low- and middle-income countries (LMICs), significant progress has been made in expanding access to noncommunicable disease (NCDs) diagnostics. Devices have been sourced....
by Esme Fowler-Mason | Nov 27, 2025 | Healthcare Systems, NCD Solutions, News
Noncommunicable diseases (NCDs) are on the rise across low- and middle-income countries (LMICs), adding pressure to already complex health supply chains. Ensuring consistent, affordable access to essential NCD medicines remains a critical, and often under-addressed,...
by Esme Fowler-Mason | Oct 23, 2025 | Access to Care, NCD Solutions, News
Rituximab, a life-saving monoclonal antibody used in the treatment of blood cancers, is now available as a biosimilar through NCDconnect, ensuring quality, affordability, and access to targeted cancer therapies across low- and middle-income countries (LMICs). Pharmacy...
by Esme Fowler-Mason | Jul 15, 2025 | Access to Care, NCD Solutions, News
The collaboration between IDA Foundation’s NCDconnect initiative and the Access to Oncology Medicines (ATOM) Coalition, led by the Union for International Cancer Control (UICC), is making significant strides toward improving access to cancer care in low- and...
by Esme Fowler-Mason | Dec 16, 2024 | NCD Solutions, News
Welcome to NCDconnect, your Digital Procurement Platform for essential medicines and medical devices against noncommunicable diseases (NCD). Signing up is straightforward, and this guide will help you complete the process with ease. Who can Use NCDconnect’s...
by Esme Fowler-Mason | Dec 13, 2024 | Access to Care, NCD Solutions, News
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
